THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

BlackRock, Inc.'s Holding History (CIK: 0002012383)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 4,050,525 Value ($000) $75,785 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 4,068,994 Value ($000) $59,407 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 4,139,025 Value ($000) $45,653 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 3,451,329 Value ($000) $30,820 Avg Close $9.31 Range $8.35 - $10.90

Q4 2024

Shares 3,712,303 Value ($000) $34,933 Avg Close $9.10 Range $7.88 - $10.26

Q3 2024

Shares 3,731,305 Value ($000) $30,074 Avg Close $8.66 Range $7.44 - $10.42

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	4,050,525	$75,785	$16.59	$13.50 - $20.33
Q3 2025	4,068,994	$59,407	$12.64	$10.82 - $14.87
Q2 2025	4,139,025	$45,653	$9.72	$7.90 - $11.82
Q1 2025	3,451,329	$30,820	$9.31	$8.35 - $10.90
Q4 2024	3,712,303	$34,933	$9.10	$7.88 - $10.26
Q3 2024	3,731,305	$30,074	$8.66	$7.44 - $10.42